CVC Capital, Yikang Medicine Chain deal published by China's SAMR for simple case review
MLex Summary: The proposed acquisition by private equity firm CVC Capital Partners of a stake in Xi’an Yikang Medicine Chain has been published for a simple case review by the Antimonopoly...To view the full article, register now.
Already a subscriber? Click here to view full article